Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia
Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS
CellCarta and Imagene AI Expand CRO Collaboration to Validate and Deploy AI-Powered Biomarker and CDx Programs With Leading Pharma Partners
Emerald Clinical Trials Appoints Former Novotech COO Michael Stibilj as CEO to Lead Next Phase of Asia-Pacific CRO Growth Read more
BioToxTech Targets 200% Growth in U.S. and European Non-Clinical CRO Orders With Bundled Turnkey Package Model Read more
Parexel Launches FSP Integrated Solutions to Move Beyond Headcount-Based CRO Outsourcing With AI-Enabled Outcomes Model Read more
WELL Health Launches WELL Research as Integrated CRO, SMO, and Bioanalytical Platform Built on Canada’s Largest Outpatient Network Read more
Everest Clinical Research Acquires Firma Clinical Research’s Data Services Unit to Expand Global Biometrics CRO Capabilities Read more
Oncodesign Services and Nexus BioQuest Partner to Give Biotech Sponsors a Clearer Route to Specialist Preclinical CRO Expertise Read more
Sygnature Discovery Formalizes DEL Screening CRO Collaboration With X-Chem to Widen Hit-Finding Options for Drug Discovery Programs Read more
McKesson Acquires Global CRO Precision Medicine Group for $2.25B to Deepen Oncology Clinical Research Capabilities Read more
Alpha Genesis Launches AGI Ventures With $50M Commitment to Co-Invest in Biotech Programs Through Its Preclinical CRO Platform Read more
Fortrea Acquires Worldwide Clinical Trials’ Early Phase Division for $45M to Add 200-Bed CPU and GLP Bioanalytical Lab Read more
The Emmes Group Names Dr. Rama Kondru CEO to Accelerate AI-Driven Clinical Trial Innovation Read more
Novotech Opens Tokyo CRO Office to Support Japanese Biopharma Sponsors Advancing Into Global Markets Read more
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study of Gemini in Acute Kidney Injury Read more
Clinilabs Appoints IQVIA Veteran Laura Shannon as CEO to Lead CNS CRO Into Next Growth Phase Read more
BioCytics and LIDE Biotech Form CRO Alliance to Develop PDX Screening Platforms for Immuno-Oncology Cell Therapy Read more